Infectious Diseases in Obstetrics and Gynecology最新文献

{"title":"Azithromycin in the Treatment of Preterm Prelabor Rupture of Membranes Demonstrates a Lower Risk of Chorioamnionitis and Postpartum Endometritis with an Equivalent Latency Period Compared with Erythromycin Antibiotic Regimens.","authors":"Daniel Martingano,&nbsp;Shailini Singh,&nbsp;Antonina Mitrofanova","doi":"10.1155/2020/2093530","DOIUrl":"https://doi.org/10.1155/2020/2093530","url":null,"abstract":"<p><strong>Objective: </strong>To determine if antibiotic regimens including azithromycin versus erythromycin has an impact on pregnancy latency and development of clinical chorioamnionitis in the context of preterm prelabor rupture of membranes. <i>Study Design</i>. We conducted a prospective observational cohort study and followed all women receiving antibiotic regimens including either azithromycin or erythromycin in the context of preterm prelabor rupture of membranes. Primary outcomes were the duration of pregnancy latency period and development of chorioamnionitis. Secondary outcomes included neonatal sepsis with positive blood culture, cesarean delivery, postpartum endometritis, and meconium-stained amniotic fluid.</p><p><strong>Results: </strong>This study included 310 patients, with 142 receiving the azithromycin regimen and 168 receiving the erythromycin regimen. Patients receiving the azithromycin regimen had a statistically significant advantage in overall rates of clinical chorioamnionitis (13.4% versus 25%, <i>p</i> = 0.010), neonatal sepsis (4.9% versus 14.9%, <i>p</i> = 0.004), and postpartum endometritis (14.8% versus 31%, <i>p</i> = 0.001). In crude and adjusted models, when comparing the azithromycin group with the erythromycin group, a decreased risk was noted for the development of clinical chorioamnionitis, neonatal sepsis, and postpartum endometritis. Pregnancy latency by regimen was not significantly different in crude and adjusted models.</p><p><strong>Conclusion: </strong>Our study suggests that latency antibiotic regimens substituting azithromycin for erythromycin have lower rates and decreased risk of clinical chorioamnionitis, neonatal sepsis, and postpartum endometritis with no difference in pregnancy latency.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"2093530"},"PeriodicalIF":0.0,"publicationDate":"2020-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/2093530","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38185605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of Genotypes and Subtypes of <i>Gardnerella vaginalis</i> in South African Pregnant Women.","authors":"Kayla Pillay,&nbsp;Silondiwe Nzimande,&nbsp;Meleshni Naicker,&nbsp;Veron Ramsuran,&nbsp;Partson Tinarwo,&nbsp;Nathlee Abbai","doi":"10.1155/2020/3176407","DOIUrl":"https://doi.org/10.1155/2020/3176407","url":null,"abstract":"<p><strong>Background: </strong><i>Gardnerella vaginalis</i>, a microorganism highly linked to bacterial vaginosis (BV), is understudied in terms of genotypic heterogeneity in South African populations. This study investigated the prevalence of <i>G. vaginalis</i> genotypes in BV-positive, BV-intermediate, and BV-negative South African pregnant women.</p><p><strong>Methods: </strong>The study population included <i>n</i> = 354 pregnant women recruited from a public hospital in Durban, South Africa. The women provided self-collected vaginal swabs for BV diagnosis by Nugent scoring. For the genotyping assays, the <i>16S rRNA</i> and <i>sialidase A</i> genes from BV-negative, BV-intermediate, and BV-positive samples were amplified with <i>G. vaginalis</i>-specific primers. The<i>16S rRNA</i> amplicon was digested with <i>TaqI</i> to generate genotyping profiles, and subtypes were determined by correlating <i>BamHI</i> and <i>HindIII</i> digestion profiles. Phylogenetic analysis was performed on the <i>16S rRNA</i> and <i>sialidase A</i> sequences. The data analysis was performed with R Statistical Computing software, version 3.6.2.</p><p><strong>Results: </strong>Two different genotypes, GT1 and GT2, were detected. The most prevalent genotype was GT1. Four subtypes (1, 2B, 2AB, and 2C) were shown to be present. The most prevalent subtype was 2B, followed by subtypes 1, 2C, and 2AB. The phylogenetic analysis of the <i>16S rRNA</i> showed the presence of 5 clusters. The tree displayed clusters which contained sequences from the same BV group with different genotypes and subtypes. Clusters with sequences from across the BV groups carrying the same genotype and subtype were present. Diversity of the <i>sialidase A</i> across BV groups and genotypes was observed. Finally, the study did not find a significant association (<i>p</i> > 0.05) between reported symptoms of abnormal vaginal discharge and genotype harboured.</p><p><strong>Conclusion: </strong>This study provided the first report on the diversity of <i>G. vaginalis</i> in South African pregnant women. Diversity assessments of <i>G. vaginalis</i> with respect to genotypes and virulence factors may aid in a greater understanding of the pathogenesis of this microorganism.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"3176407"},"PeriodicalIF":0.0,"publicationDate":"2020-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3176407","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38186089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hepatitis B Virus Infection and Its Determinants among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis.","authors":"Addisu Alehegn Alemu,&nbsp;Liknaw Bewket Zeleke,&nbsp;Bewket Yesarah Aynalem,&nbsp;Getachew Mullu Kassa","doi":"10.1155/2020/9418475","DOIUrl":"https://doi.org/10.1155/2020/9418475","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis B virus (HBV) is an infectious and a global public health problem. The prevalence of HBV infection among pregnant women is between 2.3% and 7.9%. HBV infection during pregnancy is associated with prenatal transmission to the fetus. HBV has an effective vaccine which reduces up to 96% of the transmission. Although different studies were conducted in Ethiopia, none of them showed the national prevalence of HBV infection among pregnant women. Therefore, this study was conducted to determine the pooled prevalence of HBV and its associated factors in Ethiopia.</p><p><strong>Methods: </strong>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for articles. All observational published studies were retrieved using relevant search terms in Google Scholar, African Online Journal, CINAHL, and PubMed databases. Newcastle-Ottawa assessment checklist for observational studies was used for critical appraisal of the included articles. The meta-analysis was done with STATA version 14 software. The <i>I</i> ² statistics were used to test heterogeneity whereas Begg's and Egger's tests were used to assess publication bias. Odds ratio (OR) with a 95% confidence interval (CI) was presented using the forest plot.</p><p><strong>Results: </strong>A total of twenty-three studies were included in this systematic review and meta-analysis. The pooled prevalence of HBV in Ethiopia was 4.75% (95% CI: 4.06, 5.44). The subgroup analysis showed a higher prevalence of HBV infection among pregnant women in Gambella (7.9%) and the lowest in Southern Nations, Nationalities, and Peoples' Region (SNNPR) (2.3%). Associated factors with HBV infection include history of multiple sexual partner (OR = 6.02 (95%CI = 3.86, 9.36)), blood transfusion history (OR = 5.71 (95%CI = 3.25, 10.04)), abortion history (OR = 3.58 (95%CI = 2.10, 6.09)), and history of body tattoo (OR = 2.83 (95%CI = 1.55, 5.17)).</p><p><strong>Conclusions: </strong>HBV infection among pregnant women is a common public health problem in Ethiopia. Multiple sexual partners, abortion history, blood transfusion history, and body tattoo were significantly associated with HBV infection. Policies and strategies should focus on factors identified in this study to improve the prevention of HBV among pregnant women.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"9418475"},"PeriodicalIF":0.0,"publicationDate":"2020-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/9418475","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38083155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of <i>Ureaplasma</i> Biovars and Subtyping of <i>Ureaplasma parvum</i> among Women Referring to a University Hospital in Morocco.","authors":"Safae Karim,&nbsp;Chahrazed Bouchikhi,&nbsp;Abdelaziz Banani,&nbsp;Hinde E L Fatemi,&nbsp;Tiatou Souho,&nbsp;Sanaa Erraghay,&nbsp;Bahia Bennani","doi":"10.1155/2020/7286820","DOIUrl":"https://doi.org/10.1155/2020/7286820","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to determine the prevalence of <i>Ureaplasma</i> biovars and <i>Ureaplasma parvum</i> (<i>U. parvum</i>) serovars, their associated risk factors, and genital STI-related symptoms.</p><p><strong>Methods: </strong>DNA obtained from cervical samples of 1053 women attending the department of Obstetrics and Gynecology and the laboratory of pathological anatomy of Hassan II university hospital of Fez, Morocco, was used to detect <i>Ureaplasma</i> biovars (<i>U. urealyticum</i> and <i>U. parvum</i>) and to subtype <i>U. parvum</i> by polymerase chain reaction (PCR).</p><p><strong>Results: </strong>Of the 1053 women examined, 25.4% (268/1053) were <i>Ureaplasma</i> positives. The rates of <i>U. urealyticum</i> and <i>U. parvum</i> were 12.1% (128/1053) and 7% (74/1053), respectively, and the copresence of these biovars was noted in 6.3% (66/1053) cases. The <i>U. parvum</i> subtyping revealed a predominance of the serovar 3/14 (61.4%). The association of demographics variables with <i>Ureaplasma</i> biovars was studied and shows that the age (\"<30\" years) seems to be a risk factor of <i>Ureaplasma</i> spp. and <i>U. urealyticum</i> carriage (OR 1.729, 95% CI [1.113-2.687] and OR 1.848, 95% CI [1.026-3.330], respectively). There was no difference in the prevalence of <i>Ureaplasma</i> type regarding symptoms. However, a significant association was found between <i>U. parvum</i> serovar 1 and infertility (<i>P</i> = 0.011).</p><p><strong>Conclusion: </strong>This first study conducted in Morocco provides an idea on <i>Ureaplasma</i> biovars and <i>U. parvum</i> serovars circulating in this region, their associated risk factors, and genital STI-related symptoms. Therefore, further studies are required to clarify and confirm the pathogenic role of these <i>Ureaplasma</i> species.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"7286820"},"PeriodicalIF":0.0,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7286820","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38067306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Role of Highly Active Antiretroviral Therapy (HAART) on Interleukin 17A (IL-17A) in Normotensive and Preeclamptic Black South African Women.","authors":"Wendy N Phoswa,&nbsp;Thajasvarie Naicker,&nbsp;Veron Ramsuran,&nbsp;Jagidesa Moodley","doi":"10.1155/2020/3417632","DOIUrl":"https://doi.org/10.1155/2020/3417632","url":null,"abstract":"<p><strong>Introduction: </strong>Interleukin 17A has been implicated in the pathophysiology of both human immune deficiency virus and preeclampsia. This study evaluated serum levels of IL-17A based on pregnancy type, gestational age, HIV status, and duration of HAART. <i>Material and Methods</i>. A sample size of 250 was analysed: normotensives (<i>n</i> = 150; N) and preeclamptics (<i>n</i> = 100; PE). Normotensives were further stratified into HIV negative (<i>n</i> = 90), HAART-acute (<i>n</i> = 30), and HAART-chronic (<i>n</i> = 30). The PE group was divided into early onset (<i>n</i> = 50; EOPE) and late onset (<i>n</i> = 50; LOPE). The EOPE and LOPE groups were subdivided into HIV negative (<i>n</i> = 30), HAART-acute (<i>n</i> = 10), and HAART-chronic (<i>n</i> = 10). Analysis of IL-17A was performed using a multiple Bio-Plex immunoassay method.</p><p><strong>Results: </strong>Pregnancy type: the levels of IL-17A were increased in PE compared to N (<i>P</i> = 0.0014). Gestational age: the levels of IL-17A were increased in EOPE compared to N group (<i>P</i> = 0.0113). A significant increase in the levels of IL-17A in LOPE compared to N was observed (<i>P</i> = 0.0063). HIV status: the levels of IL-17A were increased in PE compared to N (<i>P</i> = 0.0114) and in EOPE compared to N groups (<i>P</i> = 0.0071). HAART duration: the concentration of IL-17A was increased in HAART-chronic PE compared to N groups (<i>P</i> = 0.0062). There was also an increase in the levels of IL-17A in EOPE compared to N (<i>P</i> = 0.0029).</p><p><strong>Conclusion: </strong>The study demonstrates that IL-17A is involved in the pathophysiology of PE and that in the presence of HIV infection, chronic HAART administration predisposes women to the development of EOPE.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"3417632"},"PeriodicalIF":0.0,"publicationDate":"2020-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3417632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38059628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Need for Standardization of the Diagnosis and Treatment of Pelvic Inflammatory Disease: Pilot Study in an Outpatient Clinic in Quito, Ecuador.","authors":"Francisco Cueva, Andrés Caicedo, Paula Hidalgo","doi":"10.1155/2020/5423080","DOIUrl":"10.1155/2020/5423080","url":null,"abstract":"<p><strong>Background: </strong>Pelvic inflammatory disease (PID) diagnosis is often challenging as well as its treatment. This study sought to characterize the diagnostic and therapeutic trend among physicians at the outpatient level, in Quito, Ecuador, where currently no nationwide screening or specific clinical guideline has been implemented on PID or its main microbiological agents.</p><p><strong>Methods: </strong>A retrospective analysis of medical records with pelvic inflammatory disease diagnosis in an outpatient clinic was performed. Electronic medical records from 2013 to 2018 with any pelvic inflammatory disease-related diagnoses were retrieved. Information with regard to age, sexually related risk factors, symptoms and physical exam findings, ancillary tests, method of diagnosis, and antibiotic regimens was extracted.</p><p><strong>Results: </strong>A total of 186 records were included. The most frequent clinical manifestations were vaginal discharge (47%) and pelvic pain (39%). In the physical examination, leucorrhea was the most frequent finding (47%), followed by lower abdominal tenderness (35%) and cervical motion tenderness in 51 patients (27%). A clinical diagnosis was established in 60% of patients, while 37% had a transvaginal sonography-guided diagnosis. Antibiotic treatment was prescribed with standard regimens in 3% of cases, while other regimens were used in 93% of patients. Additionally, an average of 1.9 drugs were prescribed per patient, with a range from 1 to 5, all in different combinations and dosages.</p><p><strong>Conclusions: </strong>No standardized methods of diagnosis or treatment were identifiable. These findings highlight the need for standardization of the diagnosis and treatment of PID attributed to chlamydial and gonococcal infections.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"5423080"},"PeriodicalIF":0.0,"publicationDate":"2020-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5423080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37974694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HIV Screening During Pregnancy in a U.S. HIV Epicenter.","authors":"Alec Szlachta-McGinn,&nbsp;Alexandra Aserlind,&nbsp;Lunthita Duthely,&nbsp;Sean Oldak,&nbsp;Ruchi Babriwala,&nbsp;Emily Montgomerie,&nbsp;JoNell Potter","doi":"10.1155/2020/8196342","DOIUrl":"https://doi.org/10.1155/2020/8196342","url":null,"abstract":"<p><strong>Background: </strong>The CDC and ACOG have issued guidelines for HIV screening in pregnancy for patients living in areas with high prevalence of HIV in order to minimize perinatal vertical transmission. There is a lack of data examining providers' compliance with these guidelines in at-risk patient populations in the United States.</p><p><strong>Objective: </strong>To evaluate if HIV screening in pregnant women was performed according to guidelines at a large, urban, tertiary care medical center in South Florida. <i>Study Design</i>. A retrospective review was performed on 1270 prenatal and intrapartum records from women who delivered a live infant in 2015 at a single institution. Demographic and outcome data were chart abstracted and analyzed using arithmetic means and standard deviations.</p><p><strong>Results: </strong>Of the 1270 patients who met inclusion criteria, 1090 patients initiated prenatal care in the first or second trimester and delivered in the third trimester. 1000 (91.7%) patients were screened in the first or second trimester; however, only 822 (82.2%) of these were retested in the third trimester during prenatal care. Among the 178 patients lacking a third trimester test, 159 (89.3%) received rapid HIV testing upon admission for delivery. Of the 1090 patients who initiated prenatal care in the first or second trimester and delivered in the third trimester, 982 (90.1%) were screened in accordance with recommended guidelines. Of the 1270 patients initiating care in any trimester, 24 (1.9%) had no documented prenatal HIV test during prenatal care, however 22 (91.7%) had a rapid HIV test on admission for delivery. Two (0.16%) patients were not tested prenatally or prior to delivery.</p><p><strong>Conclusion: </strong>Despite 99.8% of women having at least one HIV screening test during pregnancy, there is room for improvement in routine prenatal screening in both early pregnancy and third trimester prior to onset of labor in this high-risk population.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"8196342"},"PeriodicalIF":0.0,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8196342","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37974695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Phase I Study in Healthy Women of a Novel Antimycotic Vaginal Ovule Combining Econazole and Benzydamine.","authors":"A F D Di Stefano,&nbsp;M M Radicioni,&nbsp;A Vaccani,&nbsp;G Caccia,&nbsp;F Focanti,&nbsp;E Salvatori,&nbsp;F Pelacchi,&nbsp;R Picollo,&nbsp;M T Rosignoli,&nbsp;S Olivieri,&nbsp;G Bovi,&nbsp;A Comandini","doi":"10.1155/2020/7201840","DOIUrl":"https://doi.org/10.1155/2020/7201840","url":null,"abstract":"Purpose A novel fixed-dose combination of 150 mg of econazole with 6 mg of benzydamine formulated in vaginal ovules was investigated in a randomised, double-blind, four-parallel group, tolerability, and pharmacokinetic Phase I study in healthy women. Methods The fixed-dose combination was compared to econazole and benzydamine single-drug formulations and with placebo after daily applications for 3 consecutive days. Safety and tolerability were evaluated recording the adverse drug reactions, local and general tolerability scores, clinical laboratory assays, and vital signs. Econazole, benzydamine, and its metabolite benzydamine N-oxide pharmacokinetics were investigated after single and multiple applications. Results Local reactions were generally absent. Pruritus and pain at the application site were infrequently reported. According to the subjects' evaluations, the overall tolerability of the ovules was rated as excellent or good. No significant effect of any treatment on laboratory parameters, vital signs, body weight, vaginal pH, or ECG was observed. Very low econazole, benzydamine, and benzydamine-N-oxide concentrations were measured in plasma, though quantifiable in almost all samples. Conclusion The tested fixed-dose combination showed a good safety profile consistently with the known tolerability of both active substances. In addition, the confirmed low bioavailability of the drugs excludes the possibility of any accumulation effects and limits the risk of undesired systemic effects. This trial is registered at ClinicalTrials.gov with the identifier NCT02720783 last updated on 07 February 2017.","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"7201840"},"PeriodicalIF":0.0,"publicationDate":"2020-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7201840","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37939284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urinary Tract Infections among Indonesian Pregnant Women and Its Susceptibility Pattern.","authors":"Yeva Rosana,&nbsp;Dwiana Ocviyanti,&nbsp;Melissa Halim,&nbsp;Friza Yossy Harlinda,&nbsp;Rahmah Amran,&nbsp;Wafridha Akbar,&nbsp;Matthew Billy,&nbsp;Syadza Rhizky Putri Akhmad","doi":"10.1155/2020/9681632","DOIUrl":"https://doi.org/10.1155/2020/9681632","url":null,"abstract":"<p><p>Pregnant women are usually at risk of urinary tract infections (UTIs) such as asymptomatic bacteriuria. In the current multidrug-resistance era, appropriate diagnosis and treatment should be provided to avoid complications in pregnant women in developing countries, which have limited facilities, such as Indonesia. The aim of this study was to evaluate in vitro susceptibility tests. Urinary isolates were collected from 715 pregnant women who visited eight Community Health Centers in Jakarta, Indonesia, between 2015 and 2017. We identified bacterial uropathogens from samples that were positive for nitrite/leukocyte esterase (LE), using two types of VITEK cards. Since noncompliance among patients is a major problem, fosfomycin-trometamol 3 g single-dose sachets were given to the patients, and the side effects of the medication and neonatal outcomes were reported. Asymptomatic bacteriuria was found in 10.5% of the 715 pregnant women. <i>Escherichia coli</i> was the most common etiological factor (26.7%), followed by <i>Klebsiella pneumoniae</i> (20%), <i>Streptococcus agalactiae</i> (9.3%), <i>Enterobacter cloacae</i> (5.3%), <i>Enterococcus faecalis</i> (5.3%), <i>Staphylococcus saprophyticus</i> (4%), <i>Acinetobacter baumannii</i> (4%), and others. Out of 76 pregnant women who took fosfomycin-trometamol, two complained of diarrhea that subsided without medication and fever that responded to paracetamol. Neonatal outcomes showed 100% full-term and normal-weight babies. <i>E. coli</i>, including extended-spectrum beta-lactamase- (ESBL-) producing <i>E. coli</i>, was 100% susceptible to fosfomycin. Nitrite/LE test results are often used as evidence for empiric antibiotic administration for treating asymptomatic bacteriuria in pregnancy, but the diagnosis should be confirmed using culture tests. Based on in vitro susceptibility patterns and medication outcomes, fosfomycin-trometamol single dose could be administered to noncompliant UTI patients, including pregnant women.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"9681632"},"PeriodicalIF":0.0,"publicationDate":"2020-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/9681632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37904036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of Sexually Transmitted Infections in Pregnant Adolescents on Preterm Birth and Chorioamnionitis.","authors":"Esther Fuchs,&nbsp;Maggie Dwiggins,&nbsp;Erica Lokken,&nbsp;Jennifer A Unger,&nbsp;Linda O Eckert","doi":"10.1155/2020/1908392","DOIUrl":"https://doi.org/10.1155/2020/1908392","url":null,"abstract":"<p><strong>Background: </strong>Adolescents have an increased risk of preterm birth (PTB) and sexually transmitted infections (STIs). We examined the prevalence and impact of STIs (gonorrhea, chlamydia, and trichomonas) on PTB and chorioamnionitis in pregnant adolescents.</p><p><strong>Methods: </strong>This retrospective cohort study utilized the first pregnancy delivered at an urban hospital among patients ≤ 19 years old over a 5-year period. Poisson regression with robust standard errors was used to estimate prevalence ratios (PR) and 95% confidence intervals (CI) of the association between STIs and PTB (<37 weeks) and chorioamnionitis identified by clinical or placental pathology criteria.</p><p><strong>Results: </strong>739 deliveries were included. 18.8% (<i>n</i> = 139) of births were preterm. The overall prevalence of STIs during pregnancy was 16.5% (<i>Chlamydia trachomatis</i>: 13.1%, <i>n</i> = 97; <i>Trichomonas vaginalis</i>: 3.7%, <i>n</i> = 27; and <i>Neisseria gonorrheae</i>: 3.1%, <i>n</i> = 23). Detection of <i>C. trachomatis</i>, <i>T. vaginalis</i>, or <i>N. gonorrheae</i> was not associated with increased PTB. While infection with <i>N. gonorrheae</i> and <i>C. trachomatis</i> did not increase the likelihood of any chorioamnionitis, infection with <i>T. vaginalis</i> significantly increased the likelihood of any chorioamnionitis diagnosis (aPR 2.19, 95% CI 1.26-3.83).</p><p><strong>Conclusion: </strong>In this adolescent population with a high rate of PTB, in whom most received appropriate STI treatment, we did not find an association between STI during pregnancy and an increased rate of PTB. However, an infection with <i>T. vaginalis</i> was associated with an increased likelihood of chorioamnionitis. Early detection of STIs may prevent adverse pregnancy outcomes. Continued vigilance in STI screening during pregnancy, including consideration of universal <i>Trichomonas vaginalis</i> screening, is merited in this high-risk population.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"1908392"},"PeriodicalIF":0.0,"publicationDate":"2020-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/1908392","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37819713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}